Central Phlebotomy Service is categorized under Blood Related Health Services in Holden, MA and active since 1981.
Central Phlebotomy Service was established in 1981, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact John Vyrne, President at the company’s single location by writing to 697 Main St, Holden, Massachusetts MA 01520 or by phoning (508) 852-6007. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central Phlebotomy Service |
| Contact Person: | John Vyrne, President |
| Address: | 697 Main St, Holden, Massachusetts 01520 |
| Phone Number: | (508) 852-6007 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6219992 |
| Share This Business: |
Central Phlebotomy Service was started in 1981 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Vyrne, President for inquiries that concern Central Phlebotomy Service by calling the company number (508) 852-6007, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Phlebotomy Service can be found at the coordinates 42.34079,-71.83984 as well as the street address 697 Main St in Holden, Massachusetts 01520.
For its online presence, you may visit Central Phlebotomy Service’s website at and engage with its social media outlets through on Twitter and on Facebook.